Summary

The South & Central America sarcopenia treatment market was valued at US$ 189.59 million in 2022 and is expected to reach US$ 268.50 million by 2030; it is estimated to register a CAGR of 4.4% from 2022 to 2030 .

Products in Clinical Trial Phases Fuel South & Central America Sarcopenia Treatment Market

A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:

Sarcopenia Drug Under Clinical Development

Company Name

Interventions

Conditions

Clinical Trial Stage

Abbott Nutrition

Medical Food with AN777

Oral Nutritional Formula

Malnutrition

Sarcopenia

PHASE3

Nutricia Research

Dietary Supplement: Bolus ONS A

Dietary Supplement: Bolus ONS B

Dietary Supplement: Bolus ONS C

Dietary Supplement: Bolus ONS D

Sarcopenia

PHASE1

Novartis Pharmaceuticals

Drug: Bimagrumab

Sarcopenia

PHASE2

McMaster University

Behavioural: Step Reduction

Sarcopenia

PHASE1

Metabolic Technologies Inc.

Dietary Supplement: Placebo

Drug: HMB Plus Vitamin D

Behavioural: Non-Exercise

Behavioural: Exercise

Sarcopenia

PHASE1

Merck Sharp & Dohme LLC

Drug: Comparator MK-077

Drug: Comparator Placebo

Sarcopenia

PHASE2

Immunotec Inc.

Dietary Supplement: Immunocal

Dietary Supplement: Casein

Aging and Sarcopenia

PHASE2

Lijun Yang

Combination Product: 3-Month Intensive Intervention

Sarcopenia

PHASE4

Regeneron Pharmaceuticals

Drug: REGN1033 (SAR391786)

Drug: Placebo

Sarcopenia

PHASE2

Source: Company Websites and The Insight Partners Analysis

Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.

South & Central America Sarcopenia Treatment Market Overview

The sarcopenia treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. A rise in the geriatric population and the surging incidence of vitamin Deficiency fuels the sarcopenia treatment market in South & Central America.

The introduction of new regulations by the National Sanitary Surveillance Agency (ANVISA) for dietary supplements in 2018 made the entry of new brands easier in Brazil. Moreover, it helped existing brands to flourish and innovate in the country. According to a study published in the National Library of Medicine, the elderly population is rapidly growing in Brazil, resulting in an increased prevalence of chronic conditions associated with old age. The overall prevalence of sarcopenia in the elderly population in Brazil was ~20.0% in 2020. According to an article published by National Institute of Health, in 2022, the prevalence of probable sarcopenia is 42.0% in older Brazilian women.

South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Sarcopenia Treatment Market Segmentation

The South & Central America sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the South & Central America sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest South & Central America sarcopenia treatment market share in 2022.

In terms of distribution channel, the South & Central America sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest South & Central America sarcopenia treatment market share in 2022.

By country, the South & Central America sarcopenia treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America sarcopenia treatment market share in 2022.

Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the South & Central America sarcopenia treatment market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - South & Central America Market Analysis
5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030
5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis
6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Sarcopenia Treatment Market - Country Analysis
8.1 South & Central America
8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms